Learn more

EPIGENESIS PHARMACEUTICALS LLC

Overview
  • Total Patents
    49
About

EPIGENESIS PHARMACEUTICALS LLC has a total of 49 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are STEMGEN S P A, LEOPOLDO DE JESUS ESPINOSA ABD and UNIMED PHARMACEUTICALS INC.

Patent filings per year

Chart showing EPIGENESIS PHARMACEUTICALS LLCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

# Technology
#1 Medical preparations
#2 Therapeutic chemical compounds

Top inventors

# Name Total Patents
#1 Robinson Cynthia B 22
#2 Ball Howard A 17
#3 Leonard Sherry A 11
#4 Johnson Keith A 10
#5 Friedrich Ingo 6
#6 Keller Manfred 6
#7 Kerscher Stefan 6
#8 Nyce Jonathan W 4
#9 Stefan Kerscher 1
#10 Ingo Friedrich 1

Latest patents

Publication Filing date Title
WO2009032955A1 Dheas inhalation compositions
WO2006024044A2 Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrostone
WO2005011616A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
WO2005011613A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CN101123970A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
CN101119731A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
AU2004260700A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
CN101137384A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
AU2004260678A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
AU2004261294A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
AU2004260699A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CN101123971A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
AU2003276836A1 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof